Obinutuzumab Can Be Administered as a 90-minute Short Duration Infusion in Patients with Previously Untreated Follicular Lymphoma: GAZELLE End of Induction Analysis

  1. Canales, M.A.
  2. Buchholz, T.A.
  3. Bortolini, J.A.P.
  4. Fogliatto, L.M.
  5. Ishikawa, T.
  6. Izutsu, K.
  7. Salar, A.
  8. Sharman, J.P.
  9. Klingbiel, D.
  10. Pokala, S.
  11. Vorozheikina, E.
  12. Trask, P.
  13. Parreira, J.
  14. Hübel, K.
Revue:
HemaSphere

ISSN: 2572-9241

Année de publication: 2023

Volumen: 7

Número: 4

Pages: E860

Type: Lettre

DOI: 10.1097/HS9.0000000000000860 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus